Pan African Clinical Trials Registry

South African Medical Research Council, South African Cochrane Centre
PO Box 19070, Tygerberg, 7505, South Africa
Telephone: +27 21 938 0835 or +27 21 938 0967
Email: pactradmin@mrc.ac.za Website: pactr.samrc.ac.za
Trial no.: PACTR201811895697342 Date of Registration: 26/11/2018
Trial Status: Retrospective registration - This trial was registered after enrolment of the first participant
TRIAL DESCRIPTION
Public title ADJUNCTIVE USE OF TRANEXAMIC ACID TO TOURNIQUET IN REDUCING HAEMORRHAGE DURING ABDOMINAL MYOMECTOMY AT THE UNIVERSITY OF ILORIN TEACHING HOSPITAL, ILORIN: A RANDOMIZED CONTROLLED TRIAL.
Official scientific title ADJUNCTIVE USE OF TRANEXAMIC ACID TO TOURNIQUET IN REDUCING HAEMORRHAGE DURING ABDOMINAL MYOMECTOMY AT THE UNIVERSITY OF ILORIN TEACHING HOSPITAL, ILORIN: A RANDOMIZED CONTROLLED TRIAL.
Brief summary describing the background and objectives of the trial Background: Uterine fibroids are the commonest tumour of the female genital tract; about one third are symptomatic and require management. The treatment of uterine fibroids may be medical, surgical, conservative or expectant. Myomectomy is the common surgical treatment option for women failing medical management and desiring to preserve fertility and/or their uterus. The procedure is associated with heavy bleeding and many interventions have been used to reduce bleeding during myomectomy. Tourniquet is an effective method of reducing blood loss at myomectomy, however the adjunctive use of tranexamic acid with it has not been studied. Aim: The aim of the study was to determine the efficacy of perioperative intravenous tranexamic acid in further reducing blood loss at abdominal myomectomy when used as an adjunct to tourniquet. Methods: The study was a randomized double blind controlled study involving women who underwent abdominal myomectomy. Participants were randomized to either tourniquet plus intravenous tranexamic acid or tourniquet plus placebo groups using simple random sampling. The primary outcomes were the intra-operative blood loss, post-operative haematocrit values and need for intra-operative blood transfusion. The data was analyzed using the SPSS software version 23.0 and p value < 0.05 was significant. The study was reported according to the CONSORT guidelines.
Type of trial RCT
Acronym (If the trial has an acronym then please provide)
Disease(s) or condition(s) being studied Obstetrics and Gynecology
Sub-Disease(s) or condition(s) being studied Uterine Fibroids
Purpose of the trial Treatment: Surgery
Anticipated trial start date 03/09/2017
Actual trial start date 03/09/2017
Anticipated date of last follow up 04/03/2018
Actual Last follow-up date 04/03/2018
Anticipated target sample size (number of participants) 80
Actual target sample size (number of participants) 80
Recruitment status Completed
Publication URL
Secondary Ids Issuing authority/Trial register
STUDY DESIGN
Intervention assignment Allocation to intervention If randomised, describe how the allocation sequence was generated Describe how the allocation sequence/code was concealed from the person allocating the participants to the intervention arms Masking If masking / blinding was used
Factorial: participants randomly allocated to either no, one, some or all interventions simultaneously Randomised Simple randomization using a randomization table created by a computer software program Sealed opaque envelopes Masking/blinding used Care giver/Provider
INTERVENTIONS
Intervention type Intervention name Dose Duration Intervention description Group size Nature of control
Experimental Group Group I Forty (40) participants received intravenous Tranexamic acid 10 – 15 minutes before abdominal incision in combination with tourniquet tying. Group 1 were given a bolus of intravenous tranexamic acid injection of 10 mg/kg (maximum 1 g) over 10 minutes, 15 minutes (onset of action is 5-15 minutes) before abdominal incision, followed by a continuous infusion of 1 mg/kg/h added to 1 L of saline that ran for 10 hours (maximum of 1 g/10 hours) in combination with tying tourniquet17 Under appropriate anaesthesia, the patient was cleaned, draped and normal standard surgical protocol for myomectomy was observed. A midline or Pfannenstiel incision was made on the abdominal skin. This was deepened by sharp and blunt dissection into the peritoneal cavity. The uterus was delivered into the wound after noting intraabdominal findings and location of the myomas. Foleys catheter as an improvised tourniquet was then tied (in both groups) at the base of the uterus close to the insertion of the uterosacral ligaments during the surgery3. This was tied in such a way that it temporarily impedes the blood supply from the uterine vessels and the infundibulo-pelvic ligament.3. The fallopian tubes and the ovaries were carefully excluded from the line of the tourniquet to avoid direct compression and necrosis.3 A single anterior and longitudinal incision, as much as possible was made and all the myoma nodules shelled out. After removing the myomas, the uterus was reconstructed using vicryl 2. (In cases where the endometrium was breached this was closed with interrupted stitches using vicryl 2/0 or 0.) Tourniquet was then removed and hemostasis ensured. The abdomen was then closed back in layers. Standard operating techniques were adhered to during all the procedure. 40
Control Group Placebo Group 2 received only placebo (water for injection) given as bolus intravenous injection over 10 minutes, about 15 minutes before abdominal incision followed by a continuous infusion of an equivalent water for injection (volume equivalent to 1 mg/kg/h of tranexamic acid) added to 1 L of saline that ran for 10 hours in combination with tying tourniquet. The volume of bolus water for injection was the same as tranexamic acid volume of bolus injection, calculated mg/kg, for each patient17. Group 2 received only placebo (water for injection) given as bolus intravenous injection over 10 minutes, about 15 minutes before abdominal incision followed by a continuous infusion of an equivalent water for injection (volume equivalent to 1 mg/kg/h of tranexamic acid) added to 1 L of saline that ran for 10 hours in combination with tying tourniquet. The volume of bolus water for injection was the same as tranexamic acid volume of bolus injection, calculated mg/kg, for each patient17. Under appropriate anaesthesia, the patient was cleaned, draped and normal standard surgical protocol for myomectomy was observed. A midline or Pfannenstiel incision was made on the abdominal skin. This was deepened by sharp and blunt dissection into the peritoneal cavity. The uterus was delivered into the wound after noting intraabdominal findings and location of the myomas. Foleys catheter as an improvised tourniquet was then tied (in both groups) at the base of the uterus close to the insertion of the uterosacral ligaments during the surgery3. This was tied in such a way that it temporarily impedes the blood supply from the uterine vessels and the infundibulo-pelvic ligament.3. The fallopian tubes and the ovaries were carefully excluded from the line of the tourniquet to avoid direct compression and necrosis.3 A single anterior and longitudinal incision, as much as possible was made and all the myoma nodules shelled out. After removing the myomas, the uterus was reconstructed using vicryl 2. (In cases where the endometrium was breached this was closed with interrupted stitches using vicryl 2/0 or 0.) Tourniquet was then removed and hemostasis ensured. The abdomen was then closed back in layers. Standard operating techniques were adhered to during all the procedure. Estimated blood loss was calculated using the Gravimetric method: This method involved weighing abdominal packs/sponges before and after use on a scale. The pre-weighed sterile abdominal packs (weighed prior to sterilization) were used for blood loss on the sterile field while pre-weighed perineal pads were used for blood loss on the floor and other surfaces. The difference in weight between dry and soaked sponges was multiplied by 1.050 (blood density in gm./ml) to convert to volume in milliliter and this provided an estimate of blood loss1, 17. The amount of blood in the suctioning apparatus was added to what was calculated by the gravimetric method to estimate total blood loss. The site(s), size(s), number, volume and weight of the fibroid was also noted. The volume was calculated by the principle of Archimedes while a digital weighing scale (measuring to the nearest 0.01kg/10gm) was used to determine the weight. The need or otherwise for additional anti-haemorrhagic agents to manage intra-operative and post- operative haemorrhage was recorded systematically. Need for blood transfusion and the number of units transfused were also documented. This need was determined by the anaesthetist’s assessment of acceptable blood loss and clinical assessment of vital signs. The acceptable blood loss was obtained by: Hb threshold of 10 g/dl, therefore allowable blood loss was considered equal to total Blood volume (Pre-operative Haemoglobin – Haemoglobin threshold/Pre op Haemoglobin)1. The duration of the operation was noted and for the purpose of this study is defined as from uterine incision to the last stitch on the uterus1. Vital signs was obtained at 2 hours post - operation. After the operation, each patient was taken to the recovery room and subsequently transferred to the gynaecological ward. In the ward, each patient was on nil per oris for twenty four hours; intravenous fluids for hydration and calories was given for at least twenty four hours after which she was commenced on graded oral intake. Parenteral antibiotics and Analgesics were given for forty-eight hours and changed to oral medications afterwards. Continuous bladder drainage was done for twenty four hours. Stitches were removed on the seventh or eighth day post operation (depending on if it was a vertical or Pfannenstiel incision) or not at all if it was absorbable subcuticular. The patient was discharged home for follow up in the gynaecological clinic one week later. Post-operative investigations similar to what had been taken preoperatively were taken 24 hours after surgery, in essence, haemoglobin concentration, haematocrit, full blood count and bedside clotting time. Protective equipment 40 Placebo
ELIGIBILITY CRITERIA
List inclusion criteria List exclusion criteria Age Category Minimum age Maximum age Gender
1. Subjects were consenting non-pregnant women with a diagnosis of symptomatic fibroid scheduled for abdominal myomectomy. 2. Uterine size less than or equal to 28 weeks. 3. Women without pre-operative Anemia (i.e Haemoglobin concentration ≥10g/dl) 1. Women with pre-operative Anemia (i.e Haemoglobin concentration <10g/dl). 2. Uterine size greater than 28 weeks. 3. Patients concurrently on medications such as gonadotropin releasing hormone analogues, mefenamic acid and other hormones. 4. Patients with previous abdominal surgery. 5. Cases where haemostatic tourniquet use is impossible. 6. Chronic liver diseases, nephropathies, bleeding disorders and past thromboembolic disorders. 7. Known hypersensitivity to Tranexamic Acid. 8. Pregnancy . 9. Refusal of patient to consent. Adult: 18 Year(s)-44 Year(s) 18 Year(s) 44 Year(s) Female
ETHICS APPROVAL
Has the study received appropriate ethics committee approval Date the study will be submitted for approval Date of approval Name of the ethics committee
Yes 29/06/2017 UITH Ethical Research Committee
Ethics Committee Address
Street address City Postal code Country
Oke Oyi Ilorin 240213 Nigeria
OUTCOMES
Type of outcome Outcome Timepoint(s) at which outcome measured
Primary Outcome 1) Amount of perioperative blood loss using combination of gravimetric method and amount of blood in suctioning machine at the end of surgery. 2) Twenty-four hours post-operative hemoglobin and hematocrit values were obtained. Perioperative and 24 hours after surgery
Secondary Outcome 1) Changes in vital signs (pulse rate, blood pressure, respiratory rate). 2) Need for other surgical measures to stop bleeding such as uterine artery ligation, hysterectomy. 3) Need for intraoperative blood transfusion. 4) Need for use of other anti-haemorrhagic agents. Perioperative and up to 24 hours after surgery
RECRUITMENT CENTRES
Name of recruitment centre Street address City Postal code Country
Gynaecology Clinic University of Ilorin Teaching Hospital Oke Oyi Ilorin 240213 Nigeria
FUNDING SOURCES
Name of source Street address City Postal code Country
UITH Research Grant for Part 2 Project UITH, Oke Oyi Ilorin 240213 Nigeria
SPONSORS
Sponsor level Name Street address City Postal code Country Nature of sponsor
Primary Sponsor DR. AMADU MOTUNRAYO BUKOLA UITH, Oke Oyi Ilorin 240213 Nigeria Individual
COLLABORATORS
Name Street address City Postal code Country
CONTACT PEOPLE
Role Name Email Phone Street address
Principal Investigator MOTUNRAYO BUKOLA AMADU tunrayoamdu2010@gmail.com +2348063596575 UITH, Oke Oyi
City Postal code Country Position/Affiliation
Ilorin 240213 Nigeria CONSULTANT
Role Name Email Phone Street address
Public Enquiries JIMOH ABDULGAFAR jimohaag@yahoo.com +2348037252959 UITH, Oke Oyi
City Postal code Country Position/Affiliation
Ilorin 240213 Nigeria HOD
Role Name Email Phone Street address
Scientific Enquiries ISHAQ FUNSHO ABDUL abdula_dr@yahoo.com +2348037075430 UITH, Oke Oyi
City Postal code Country Position/Affiliation
Ilorin 240213 Nigeria Associate ProfessorSupervisor
REPORTING
Share IPD Description Additional Document Types Sharing Time Frame Key Access Criteria
Undecided
URL Results Available Results Summary Result Posting Date First Journal Publication Date
No
Result Upload 1: Result Upload 2: Result Upload 3: Result Upload 4: Result Upload 5:
Result URL Hyperlinks Link To Protocol
Result URL Hyperlinks
Changes to trial information